Bioinvent International
IPOUnleashing Immunity to Fight Cancer
Bioinvent International is headquartered in Lund, Sweden.
- Headquarters
- Lund
- Business Model
- B2B
- Website
- bioinvent.com
- Type
- Public
Indexed holds 2 investors for this company. The full record is or through the API.
About
BioInvent International is a Swedish clinical-stage biotechnology company that discovers and develops novel antibody-based therapeutics for cancer, using its proprietary F.I.R.S.T™ screening platform and n-CoDeR® antibody library. The company has ongoing collaborations with global pharmaceutical partners including CASI, Merck, Daiichi, and Mitsubishi Tanabe, and also provides contract antibody manufacturing services through BioInvent Manufacturing, active since 1988.
Summary
Bioinvent International is a Biotech company based in Lund, Sweden. Investors include Pfizer Ventures and HBM Healthcare Investments.
Exit History
Jul 2022
Sign up to see all 5 events
Funding, valuations, and company events, with amounts and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/bioinvent-international"><img src="https://indexed.vc/api/badge/company/bioinvent-international" alt="Bioinvent International on Indexed.vc" width="260" height="76" /></a>